Table 1.
Determination | 2 weeks after surgery | 8 weeks after surgery | ||||
---|---|---|---|---|---|---|
Control (n = 10) | Sham (n = 10) | DJB (n = 10) | Control (n = 10) | Sham (n = 10) | DJB (n = 10) | |
HR (b.p.m.) | 371.46 ± 44.72 | 393.06 ± 37.29 | 382.53 ± 45.31 | 378.23 ± 40.75 | 391.74 ± 52.33 | 380.28 ± 45.62 |
SBP (mmHg) | 121.53 ± 6.46 | 117.70 ± 8.36 | 119.14 ± 11.51 | 122.37 ± 8.16 | 119.55 ± 9.61 | 123.67 ± 10.32 |
DBP (mmHg) | 99.62 ± 6.37 | 101.21 ± 6.38 | 98.64 ± 8.12 | 95.47 ± 7.41 | 95.32 ± 7.93 | 97.61 ± 8.19 |
MAP (mmHg) | 105.14 ± 5.74 | 106.87 ± 7.51 | 104.94 ± 6.52 | 103.29 ± 7.48 | 104.11 ± 8.16 | 106.16 ± 6.87 |
TG (mmol/L) | 1.05 ± 0.31 | 2.69 ± 0.72** | 1.92 ± 0.65# , && | 1.11 ± 0.34 | 2.95 ± 0.84** | 1.43 ± 0.65## |
TC (mmol/L) | 1.80 ± 0.35 | 2.32 ± 0.49* | 1.96 ± 0.32 | 1.87 ± 0.44 | 3.60 ± 1.16** | 2.19 ± 0.73## |
HDL‐c (mmol/L) | 1.15 ± 0.27 | 0.62 ± 0.20** | 0.96 ± 0.39# | 1.21 ± 0.21 | 0.52 ± 0.25** | 1.04 ± 0.31## |
LDL‐c (mmol/L) | 0.42 ± 0.05 | 0.54 ± 0.16 | 0.47 ± 0.15 | 0.39 ± 0.08 | 0.64 ± 0.13** | 0.46 ± 0.09## |
NEFA (μmol/dL) | 22.54 ± 3.39 | 48.42 ± 9.81** | 30.83 ± 6.75## , && | 24.27 ± 4.31 | 62.43 ± 10.28** | 27.51 ± 6.20## |
Data are expressed as mean ± standard deviation, n = 10 per group. *P < 0.05, **P < 0.01 sham versus control; # P < 0.05, ## P < 0.01 duodenal‐jejunal bypass (DJB) versus sham; && P < 0.01 DJB versus control. DBP, diastolic blood pressure; HDL‐c, high‐density lipoprotein cholesterol; HR, heart rate; LDL‐c, low‐density lipoprotein cholesterol; MAP, mean arterial pressure; NEFA, non‐esterified fatty acid; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.